BRIEF-Caplin Point Laboratories Unit Signs Pact With Xellia Pharmaceuticals

CAPLIN STERILES SIGNS PACT WITH XELLIA
PHARMACEUTICALS

CAPLIN STERILES TO LICENSE 5 INJECTABLE ANDAS TO
XELLIA

APPROVAL FOR 4 PRODUCTS EXPECTED WITHIN NEXT 12-18 MONTHS Source text for Eikon.

https://www.reuters.com/article/brief-caplin-point-laboratories-ltd-capl/brief-caplin-point-laboratories-ltd-caplin-steriles-gets-usfda-approval-for-verapamil-hydrochloride-injection-usp-idUKFWN2BI1O1